Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis. | J Clin Invest | 2024 | 38618952 | PubTator, text mining | PubMed |
| Colchicine Blocks Abdominal Aortic Aneurysm Development by Maintaining Vascular Smooth Muscle Cell Homeostasis. | Int J Biol Sci | 2024 | 38617538 | PubTator, text mining | PubMed |
| Aberrant METTL14 gene expression contributes to malignant transformation of benzene-exposed myeloid cells. | Ecotoxicol Environ Saf | 2024 | 38608381 | PubTator, text mining | PubMed |
| A Stapled Peptide Inhibitor Targeting the Binding Interface of N6-Adenosine-Methyltransferase Subunits METTL3 and METTL14 for Cancer Therapy. | Angew Chem Int Ed Engl | 2024 | 38607929 | PubTator, text mining | PubMed |
| XBP1s activates METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer. | Cancer Lett | 2024 | 38582397 | PubTator, text mining | PubMed |
| Palmatine inhibits expression fat mass and obesity associated protein (FTO) and exhibits a curative effect in dextran sulfate sodium (DSS)-induced experimental colitis. | Int Immunopharmacol | 2024 | 38579565 | PubTator, text mining | PubMed |
| Classical swine fever virus non-structural protein 5B hijacks host METTL14-mediated m6A modification to counteract host antiviral immune response. | PLoS Pathog | 2024 | 38551978 | PubTator, text mining | PubMed |
| Epigenetic activation of METTL14 promotes docetaxel resistance in prostate cancer by promoting pri-microRNA-129 maturation. | Environ Toxicol | 2024 | 38546343 | PubTator, text mining | PubMed |
| NME6 as a potential biomarker and therapeutic target involved in immune infiltration for lung adenocarcinoma. | Technol Health Care | 2024 | 38517815 | PubTator, text mining | PubMed |
| Impaired binding affinity of YTHDC1 with METTL3/METTL14 results in R-loop accumulation in myelodysplastic neoplasms with DDX41 mutation. | Leukemia | 2024 | 38514771 | PubTator, text mining | PubMed |
| Endogenous retrovirus activation: potential for immunology and clinical applications. | Natl Sci Rev | 2024 | 38495812 | PubTator, text mining | PubMed |
| The antagonistic effect of FTO on METTL14 promotes AKT3 m6A demethylation and the progression of esophageal cancer. | J Cancer Res Clin Oncol | 2024 | 38491196 | PubTator, text mining | PubMed |
| METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2. | Sci Rep | 2024 | 38486042 | PubTator, text mining | PubMed |
| A neural m6A pathway regulates behavioral aggregation in migratory locusts. | Sci China Life Sci | 2024 | 38478296 | PubTator, text mining | PubMed |
| Expression patterns and prognostic role of m6A RNA methylation regulators in Non-small Cell Lung Cancer. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38430042 | PubTator, text mining | PubMed |
| Intrafamily heterooligomerization as an emerging mechanism of methyltransferase regulation. | Epigenetics Chromatin | 2024 | 38429855 | PubTator, text mining | PubMed |
| m6A methyltransferase METTL14‑mediated RP1‑228H13.5 promotes the occurrence of liver cancer by targeting hsa‑miR‑205/ZIK1. | Oncol Rep | 2024 | 38426536 | PubTator, text mining | PubMed |
| Proteolysis Targeting Chimera Degraders of the METTL3-14 m6A-RNA Methyltransferase. | JACS Au | 2024 | 38425900 | PubTator, text mining | PubMed |
| METTL14-Mediated m6a Modification of CDKN2A Promotes the Development of Retinoblastoma by Inhibiting the p53 Pathway. | Crit Rev Immunol | 2024 | 38421707 | PubTator, text mining | PubMed |
| FoxO1 promotes ovarian cancer by increasing transcription and METTL14-mediated m6A modification of SMC4. | Cancer Sci | 2024 | 38403332 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=27